Evaluation of Safety and Beneficial Health Effects of the Human-Milk Strain Bifidobacterium breve DSM32583: An Infant Pilot Trial
Nutrients · 2024
DOI: 10.3390/nu16081134 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Claudio Alba und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Science, Complutense University of Madrid, 28040 Madrid, Spain. Hauptthemen laut MEDLINE: Bifidobacterium breve, Probiotics, Milk, Human, Infant Formula. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Education and Science, HiPP GmbH and Co. Vertrieb KG.
Abstract (Originalsprache)
Human milk promotes the growth of bifidobacteria in the infant gut. Adding bifidobacterial species to infant formula may contribute to increasing their presence in the gut of formula-fed infants. Therefore, the safety and anti-infectious effects of Bifidobacterium breve DSM32583, a breast milk isolate, were assessed in a pilot trial involving 3-month-old infants. The infants were randomly assigned to either the probiotic (PG) or the control (CG) groups. All the infants consumed the same formula, although it was supplemented with the strain (1 × 107 cfu/g of formula) in the PG. Overall, 160 infants (80 per group) finished the intervention. Infants in CG gained more weight compared to PG (p < 0.05), but the weights for age Z-scores at 6 months were within the normal distribution for this age group. The rates of infections affecting the gastrointestinal and respiratory tracts and antibiotic therapy were significantly lower in the PG. The bifidobacterial population and the level of short-chain fatty acids were higher (p < 0.05) in the fecal samples of PG infants. No adverse events related to formula consumption were observed. In conclusion, the administration of an infant formula with B. breve DSM32583 was safe and exerted potential beneficial effects on gut health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Science, Complutense University of Madrid, 28040 Madrid, Spain.
- Centro de Atención Primaria Silvano, Comunidad de Madrid, 28043 Madrid, Spain.
- Department of Pediatric Gastroenterology, Hospital Universitario Gregorio Marañón, 28007 Madrid, Spain.
- Department of Galenic Pharmacy and Food Technology, Complutense University of Madrid, 28040 Madrid, Spain.
ORCID-Profile: Claudio Alba, Leónides Fernández, Juan M Rodríguez
Förderung
- Spanish Ministry of Education and Science
- HiPP GmbH and Co. Vertrieb KG
Zitieren
APA
Alba, C., Carrera, M., Álvarez-Calatayud, G., Arroyo, R., Fernández, L., & Rodríguez, J. M. (2024). Evaluation of Safety and Beneficial Health Effects of the Human-Milk Strain Bifidobacterium breve DSM32583: An Infant Pilot Trial. Nutrients. https://doi.org/10.3390/nu16081134
Vancouver
Alba C, Carrera M, Álvarez-Calatayud G, Arroyo R, Fernández L, Rodríguez JM. Evaluation of Safety and Beneficial Health Effects of the Human-Milk Strain Bifidobacterium breve DSM32583: An Infant Pilot Trial. Nutrients. 2024. doi:10.3390/nu16081134
BibTeX
@article{Alba2024,
author = {Alba, Claudio and Carrera, Marta and Álvarez-Calatayud, Guillermo and Arroyo, Rebeca and Fernández, Leónides and Rodríguez, Juan M},
title = {Evaluation of Safety and Beneficial Health Effects of the Human-Milk Strain Bifidobacterium breve DSM32583: An Infant Pilot Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16081134}
}
EUVIMED